生命科学资讯

Ono’s Deciphera drops early-stage solid tumor drug for strategic reasons

Teva bags $400M deal with Blackstone to fund Sanofi-partnered IBD drug

Picton Mahoney Asset Management Takes $17.01 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat

UCB boards T cell engager train in $60M upfront deal with Antengene

APG Asset Management N.V. Trims Stock Position in Waters Corporation $WAT - MarketBeat

Blackstone to support Teva on Sanofi-partnered TL1A with $400M

Sanofi strikes $1.5B global licensing deal for Sino Biopharm's first-in-class JAK/ROCK asset

Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com

Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition

Deep learning linking mechanistic models to single-cell transcriptomics data reveals transcriptional bursting in response to DNA damage

SLC4A1 mutations that cause distal renal tubular acidosis alter cytoplasmic pH and cellular autophagy

Correction: Opposing p53 and mTOR/AKT promote an in vivo switch from apoptosis to senescence upon telomere shortening in zebrafish

Acetylation of H3K115 is associated with fragile nucleosomes at CpG island promoters and active regulatory sites

Ancient photoreceptor shapes behavioural responses

News | Biotech giant recommits to major Wisconsin hub despite cuts across US office portfolio - CoStar

10x Genomics at TD Cowen Conference: Navigating Challenges with Strategic Initiatives - Investing.com India

Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant

Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch